Walletmed
Walletmed is a health-tech company that has developed an end-to-end healthcare ecosystem focused on metabolic health. Their core product is a subdermal implant that continuously monitors metabolic data, including glucose levels, body temperature, oxygen saturation, and heart rate. This implant is powered wirelessly by a smartwatch or smartphone with an NFC module. The collected data is processed using AI and machine learning algorithms within a smartwatch application to provide personalized lifestyle and health recommendations. Walletmed also plans to offer consultations with experts and a marketplace for conditions-related drugs and appointments with private health clinics for treatment and monitoring. Their unique selling proposition is an entirely optical glucose measurement method that requires no recalibration and a ten-year implant lifespan.
Walletmed
Walletmed is a health-tech company that has developed an end-to-end healthcare ecosystem focused on metabolic health. Their core product is a subdermal implant that continuously monitors metabolic data, including glucose levels, body temperature, oxygen saturation, and heart rate. This implant is powered wirelessly by a smartwatch or smartphone with an NFC module. The collected data is processed using AI and machine learning algorithms within a smartwatch application to provide personalized lifestyle and health recommendations. Walletmed also plans to offer consultations with experts and a marketplace for conditions-related drugs and appointments with private health clinics for treatment and monitoring. Their unique selling proposition is an entirely optical glucose measurement method that requires no recalibration and a ten-year implant lifespan.
TL;DR
Product: Passive subdermal NFC implant + smartwatch/app for continuous metabolic monitoring
Key capability: Optical (Raman-based) glucose measurement without recalibration
Headquarters: Warsaw, Poland
Founding year: 2020
Team size (reported): 4 employees
Grant and pre-seed events; total recorded ~$160k (USD)
Company Overview
Problem Domain
Metabolic health monitoring and chronic condition management
Founded
2020
Industry
Medtech / Healthtech
Tech Stack
Funding Track Record
Recorded as a pre-seed round on company profiles.
Recorded grant funding event; details obfuscated in profiles.
Investor Signal
“Andrzej Miturski listed as investor/lead in pre-seed round”